The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases
Abstract
To define clinical and laboratory characteristics of the lupus anticoagulant (LA), we reviewed our experience (219 subjects). Subjects were divided into group A, those with the LA and the diagnosis of lupus erythematosus, group B, those with the LA but nonlupus diagnoses, and group C, those with drug‐related lupus syndromes. The typical laboratory findings consisted of a prolonged and inhibited plasma clot time (an average of 1.9 times control time) which was proportionately more prolonged than the partial thromboplastin time or activated partial thromboplastin time (APTT) (average 1.3 times control). Ninety‐eight percent had a prolonged plasma clot time and 94% had a prolonged partial thromboplastin time. The prothrombin and thrombin times were prolonged in 33 and 25% of subjects, respectively. Washed platelets shortened the APTT in the 22 subjects so tested. Monoclonal protein peaks were seen in 7% of patients. Seventeen episodes of bleeding were observed, but in all but one instance there was another hemostatic defect present. In the 18 patients who underwent major operations, there were no hemorrhagic complications. Fifty‐eight episodes of thrombosis were observed with the same incidence in group A (25%) as in group B (26%). Bleeding is rare with the LA but thrombosis is common even without SLE and lupuslike syndromes. The plasma clot time in platelet‐rich plasma is more prolonged, and in our experience, is more sensitive in detecting the lupus anticoagulant than is the partial thromboplastin time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Clinical Manifestations of Systemic Lupus Erythematosus: Computer Analysis of 520 Cases
Dubois, E. L., & Tuffanelli, D. L. (1964) · JAMA · doi:10.1001/jama.1964.03070150014003 · Cited by 728
Carreras, L., Machin, S., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., & Van Assche, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Acquired inhibitors of blood coagulation.
Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521
(1963) · PubMed · Cited by 512
Boey, M. L., Colaco, C. B., Gharavi, A. E., Elkon, K. B., Loizou, S., & Hughes, G. R. (1983) · BMJ · doi:10.1136/bmj.287.6398.1021 · Cited by 508
Thrombosis in Patients with the Lupus Anticoagulant
MUEH, J. R., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 496
Cl, C. (1952) · Journal of Clinical Investigation · Cited by 482
A clinical study of the lupus anticoagulant
Schleider, M., Nachman, R., Jaffe, E., & Coleman, M. (1976) · Blood · doi:10.1182/blood.v48.4.499.499 · Cited by 470
De Wolf, F., Carreras, L. O., Moerman, P., Vermylen, J., Van Assche, A., & Renaer, M. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32527-3 · Cited by 411
Cited by
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Hirsh, J., & Hoak, J. (1996) · Circulation · doi:10.1161/01.cir.93.12.2212 · Cited by 635
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
Blank, M., Cohen, J., Toder, V, & Shoenfeld, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3069 · Cited by 455
Antiphospholipid Antibodies and venous thromboembolism
Ginsberg, J., Wells, P., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J. (1995) · Blood · doi:10.1182/blood.v86.10.3685.bloodjournal86103685 · Cited by 365
Asherson, R. A., Khamashta, M. A., Gil, A., Vazquez, J.-J., Chan, O., Baguley, E., & Hughes, G. R. V. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90335-5 · Cited by 330
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects
Vila, P., Hernández, M. C., López-Fernández, M. F., & Batlle, J. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648840 · Cited by 280
The Relationship Between Lupus Anticoagulants and Antibodies to Phospholipid
Triplett, D. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720040042024 · Cited by 252
Antiphospholipid syndrome: multiple mechanisms
MACKWORTH-YOUNG, C. G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02497.x · Cited by 114
Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
Martirosyan, A., Aminov, R., & Manukyan, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01609 · Cited by 62
Metadata
- Authors
- Gastineau, D. A., Kazmier, F. J., Nichols, W. L., & Bowie, E. J. W.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 1985-07
- Volume
- 19
- Issue
- 3
- Pages
- 265-275
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2079180127
- Cited by
- 257
- References
- 39
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.